Crystal Arthritides Word Scramble
|
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Question | Answer |
Gout epi | M 40-50 yo; F 65 yo; genetic, environmental |
Gout risk factors | infxn; trauma; wt loss (esp extreme diets); hosp; dyslipidemia (esp trigs) |
Causes of hyperuricemia: overproduction | Nutritional (purine consumption, EtOH); hematopoietic, psoriasis, drugs |
Causes of hyperuricemia: underexcretion | Nutritional (EtOH); renal / vasc; drugs (diuretics); metab / hormones |
Sx of hyperuricemia | usu asymptomatic / req no tx; look for underlying cause (HTN, metab syn) |
uric acid levels influenced by: | body habitus, ETOH use, BP, diet & insulin resistance |
4 stages of gout | hyperuricemia, acute gout, intercritical, chronic |
Hyperuricemia = uric acid level: | >6.8 mg/dL (levels inc at puberty; higher in men) |
High uric acid levels also assoc with: | HTN, metab syn, CAD, CKD |
Gout: monoarticular manifestn | 1st MTP (podagra)> instep > heel > ankle > knee; LE>UE; very painful; self limiting |
Gout clinical manifestations | very sudden; affected jt = warm, dusky red, swollen, exquisitely tender; systemic signs possible |
Gout hard to distinguish from: | septic arthritis |
Gout: Not useful in dx: | serum uric acid, plain films |
Gold standard in dx of gout | joint aspirate demonstrating uric acid crystals |
Tx of choice: acute gout | NSAIDs (indomethacin, celecoxib) |
Acute gout: other tx | colchicine (esp for prophylaxis); c’steroids (oral, IV, intra-art) for pt who cannot take NSAIDs; |
Gout tx: never … | start a drug to tx elevated uric acid in midst of acute attack; don’t stop prophylactic tx (if already on it) during acute; tx arthritis first, then hyperuricemia (not both at once) |
Gout prophylaxis | Lifestyle mods (limit offending foods, ETOH; increased fluid intake; wt loss); Eval for provoking meds (diuretics); aspirin, niacin |
Indications for gout prophylaxis: | 2 or more attacks/yr; erosive dz on plain film; uric acid nephropathy/ nephrolithiasis; chronic polyarticular gout |
gout prophylaxis: Pharmacology: | colchicine; uricosurics (probenecid); xanthine oxidase inhibitors (allopurinol, Uloric) |
uricosurics: MOA | decrease urate reabsorption, promotes excretion |
xanthine oxidase inhibitors: MOA | decrease serum uric acid levels |
prior to starting prophylaxis for acute gout: | do 24 hr urinary uric acid (<800mg/d = undersecretion; >800mg/d = overproducer) |
Acute gout prophylaxis: other | limit (3-12 mo); d/c when pt at goal (<6 mg/dL uric a. x 3-6 mo & no attacks); poss fenofibrate, losartan, vit C |
genetically engineered uricase = | Krystexxa : reduces uric acid & melts tophi; for severe chronic refractory gout |
intercritical gout | freq inc w/time in untx’d pts; subsequent attacks: less sudden, polyarticular, slower to resolve |
Hallmarks of Chronic Tophaceous Gout | destructive polyarticular dz; resemble other forms arthritis; multi tophaceous deposits (tophi) (hands, feet, helix of ear); dev about 12 yr after 1st attack; dir rel to uric a. levels; no pain-free intercritical pd |
Chronic Tophaceous Gout: tx | probenecid, allopurinol, steroids |
CPPD Epi | true prevalence unk (F > M); if FH, usu presentation <50 yo |
CPPD etio | idiopathic or associated with primary dz (hyperPTH, hypothyroid, hemochromatosis, hypophosphatemia) |
CPPD risk factors | trauma (can be minor), MI, CVA, infxn, surg (knee arthroscopy, ?intra-art hyaluronate) |
CPPD clin presentation: if sx: | If sx, varies: can mimic RA, OA, gout; post-traumatic hemarthrosis; systemic illness (pseudo-PMR); axial dz (c-spine stenosis) |
CPPD clin presentation: sudden onset | (sim to gout); systemic sx (fever, chills, inc acute phase reactants); acute poss in setting of chronic arthropathy; may worsen OA when both exist |
CPPD dx | demo crystals in jt fluid; chondrocalcinosis on plain film; CT, MRI and U/S all detect CPPD; do serum Ca, Mg, PO4, alk phos, ferritin, Fe, TIBC |
CPPD tx | Tx underlying dz; no spec tx for idiopathic dz; poss: NSAIDs / celecoxib; c’steroids (IV, po, intra-art); LD colchicine; hydroxychloroquine; arthrocentesis |
BCP crystals have a predilection for: | the shoulder |
BCP clinical presentations: | calcific tendinitis; Milwaukee shoulder; subacromial bursitis; knee & hip poss; |
BCP tx | NSAIDS, physical therapy |
Calcific tendonitis: | 4t/5t decades; DM (esp ins-dept); deposits in rotator cuff; often resolve spont |
Milwaukee shoulder: | rare arthropathy (usu elderly women); rapid rotator cuff & GHJ destn; assoc w/ lg hematomas, bloody synovial fluid |
CPPD fx where: | large joints (knee, wrist, elbow); chondrocalcinosis; also MCPs, hips, shoulders, ankles |
Created by:
Abarnard
Popular Medical sets